Table 5. Intention-to-treat sensitivity estimates for all endpoints and primary contrasts.
| Measure |
Contrast |
ITT estimate |
95% CI |
Hedges
g |
p |
| TQR
(a.u.) |
T1-T0 |
ΔΔ
0.60 TQR points |
0.28 to
0.93 |
0.78 |
<
0.001 |
| TQR
(a.u.) |
T2-T0 |
ΔΔ
0.11 TQR points |
-0.38 to
0.59 |
0.14 |
0.662 |
| Cortisol
(nmol/L) |
T1-T0 |
RRR 1.04 |
0.98 to
1.10 |
0.36 |
0.199 |
| Cortisol
(nmol/L) |
T2-T0 |
RRR 0.99 |
0.93 to
1.06 |
-0.09 |
0.788 |
| Resting
HR (bpm) |
T1-T0 |
ΔΔ
-2.10 bpm |
-2.24 to
-1.96 |
-0.64 |
<
0.001 |
| Resting
HR (bpm) |
T2-T0 |
ΔΔ
-0.00 bpm |
-0.14 to
0.14 |
-0.00 |
0.961 |
| lnRMSSD
(log units) |
T1-T0 |
ΔΔ
0.122 log units |
0.108 to
0.137 |
0.75 |
<
0.001 |
| lnRMSSD
(log units) |
T2-T0 |
ΔΔ
-0.002 log units |
-0.016
to 0.011 |
-0.01 |
0.722 |
| RMSSD
(ms) |
T1-T0 |
ΔΔ
8.02 ms |
6.99 to
9.04 |
0.77 |
<
0.001 |
| RMSSD
(ms) |
T2-T0 |
ΔΔ
-0.15 ms |
-1.00 to
0.70 |
-0.01 |
0.722 |
| SDNN
(ms) |
T1-T0 |
ΔΔ
10.47 ms |
6.52 to
14.42 |
0.64 |
<
0.001 |
| SDNN
(ms) |
T2-T0 |
ΔΔ
0.84 ms |
-3.00 to
4.69 |
0.05 |
0.662 |
| PORH
Peak (PU) |
T1-T0 |
ΔΔ
0.55 PU |
-0.99 to
2.10 |
0.13 |
0.477 |
| PORH
Peak (PU) |
T2-T0 |
ΔΔ
0.14 PU |
-0.59 to
0.87 |
0.03 |
0.703 |
| Resting
flow RF (PU) |
T1-T0 |
ΔΔ
0.18 PU |
-0.13 to
0.49 |
0.09 |
0.243 |
| Resting
flow RF (PU) |
T2-T0 |
ΔΔ
0.03 PU |
-0.29 to
0.34 |
0.01 |
0.851 |
| Time
to peak TTP (s) |
T1-T0 |
ΔΔ
-0.04 s |
-0.76 to
0.69 |
-0.01 |
0.918 |
| Time
to peak TTP (s) |
T2-T0 |
ΔΔ
0.22 s |
-0.11 to
0.55 |
0.05 |
0.180 |
| Recovery
time (min) |
T1-T0 |
ΔΔ
0.03 min |
-0.18 to
0.24 |
0.03 |
0.759 |
| Recovery
time (min) |
T2-T0 |
ΔΔ
-0.09 min |
-0.19 to
0.01 |
-0.10 |
0.070 |
Estimates are ΔΔ (contrast minus control), except cortisol, which is reported as a ratio of ratios (RRR). CI, confidence interval; HR, heart rate; HRV, heart rate variability; PORH, post-occlusive reactive hyperemia; TQR, Total Quality Recovery.
